-+ 0.00%
-+ 0.00%
-+ 0.00%

Microbot Medical posts negative Q3 gross margin; Q3 revenue drops 70% from Q2 to $72,000

PUBT·11/16/2026 13:34:03
Listen to the news
Microbot Medical posts negative Q3 gross margin; Q3 revenue drops 70% from Q2 to $72,000
  • Microbot Medical third-quarter 2026 revenue fell 70% from the second quarter to $72,000 due to customer reorder timing and summer seasonality.
  • Gross margin was negative, hurt by an inventory write-down and higher production costs for units manufactured in earlier periods.
  • Quarter-end cash, cash equivalents and marketable securities totaled approximately $62 million, while customer accounts increased to 12.
  • Following Israeli regulatory approval, the company signed a three-year exclusive distribution agreement with Medtechnica to market and sell LIBERTY in Israel.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Microbot Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-052054), on November 16, 2026, and is solely responsible for the information contained therein.